About Us

Embark Biotech is a privately owned company, founded in 2017 as a spin-out from the NNF Center for Basic Metabolic Research at the University of Copenhagen.

Founders

Klaus Schollmeier

Chairman

30+ years experience in pharma and biotech management. Ex-CEO SuppreMol & Santhera.

Casper Tind Hansen

CEO

15+ years of experience from pharma, venture investments & biotech management. Ex-CEO Pcovery and co-founder of Orphazyme and Ceremedy.

Zach Gerhart-Hines

CSO

Associate professor. 10+ years experience in the obesity and diabetes fields with a focus on adipose tissue metabolism, specifically energy expenditure.

Jakob Bondo Hansen

Head of research

10+ years experience in the obesity and diabetes fields with a focus on endocrine and adipose tissue physiology and pharmacology.

Thue Schwartz

Scientific godfather

30+ years experience in G protein-coupled receptor pharmacology with a focus on receptor-based innovation and commercialization.